RT Journal Article
SR Electronic
T1 CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006704
DO 10.1136/jitc-2023-006704
VO 11
IS 6
A1 Gao, Jing
A1 Wang, Zhengyi
A1 Jiang, Wenqing
A1 Zhang, Yanni
A1 Meng, Zhen
A1 Niu, Yanling
A1 Sheng, Zhen
A1 Chen, Chan
A1 Liu, Xuejun
A1 Chen, Xi
A1 Liu, Chanjuan
A1 Jia, Keren
A1 Zhang, Cheng
A1 Liao, Haiyan
A1 Jung, Jaeho
A1 Sung, Eunsil
A1 Chung, Hyejin
A1 Zhang, Jingwu Z.
A1 Zhu, Andrew X.
A1 Shen, Lin
YR 2023
UL http://jitc.bmj.com/content/11/6/e006704.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.